Format

Send to

Choose Destination
Can Urol Assoc J. 2015 May-Jun;9(5-6):E387-9. doi: 10.5489/cuaj.2768.

Port site metastasis in prostate cancer.

Author information

1
University Hospital of Ghent, Ghent, Belgium;
2
Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium.

Abstract

Port-site metastasis of prostatic adenocarcinoma is rare and usually associated with poor prognosis. We report a case of a young man with a rising prostate-specific antigen (PSA) 4.5 years after robot-assisted laparoscopic prostatectomy (RALP) and extended pelvic lymphadenectomy (ePLND) for a Gleason 7 (4+3) prostate cancer (pT3b pN0 cM0). Choline positron emission tomography-computed tomography (PET-CT) demonstrated a PET positive subcutaneous recurrence in a previous trocar site accompanied by a PET positive ipsilateral inguinal lymph node. Excision of both lesions was performed, confirming the diagnosis of metastatic prostate cancer. The patient's PSA dropped significantly postoperatively enabling postponement of androgen deprivation treatment up to this date. The etiology of port-site metastasis is multifactorial, including patient and surgery related factors. Such metastases have been scarcely reported following ePLND with or without RALP. Certain surgical precautions can be made to prevent the occurrence. We summarize previously reported mechanisms of development and possible precautionary measures.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center